Altimmune, Inc. (ALT)
5.34
-0.09
(-1.66%)
USD |
NASDAQ |
Dec 11, 16:00
5.52
+0.18
(+3.37%)
Pre-Market: 08:22
Altimmune Research and Development Expense (TTM): 67.72M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viking Therapeutics, Inc. | 222.48M |
| Eli Lilly & Co. | 12.56B |
| Pfizer Inc. | 10.13B |
| Terns Pharmaceuticals, Inc. | 76.99M |
| Rhythm Pharmaceuticals, Inc. | 165.86M |